acetylcysteine has been researched along with celecoxib in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 8 (66.67) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Figueiredo-Pereira, ME; Jansen, M; Li, Z; Rockwell, P | 1 |
| Ali, F; Birdsey, GM; Dumont, O; Evans, PC; Hamdulay, SS; Haskard, DO; Mason, JC; Wang, B; Wheeler-Jones, CP | 1 |
| Azzolina, A; Cervello, M; Lampiasi, N; McCubrey, JA; Montalto, G; Umezawa, K | 1 |
| Aghazarian, M; Cucchi, S; Galmarini, F; Goldschmidt, P; Golomar, W; Gordon, W; Lasalvia-Galante, E; Lasalvia-Prisco, E; Vázquez, J | 1 |
| Chang, CC; Cheng, TJ; Chuang, HC; Chuang, KJ; Hsueh, TW; Hwang, JS; Yan, YH | 1 |
| Balbontín-Ayala, F; Cañigral, A; Carlos, Fd; Cobo, T; Fernández-González, FJ; Fernández-Vázquez, JP; Gonzalo-Orden, JM; Sánchez-Lasheras, F; Vega, JA | 1 |
| Asthana, S; Chaturvedi, S; Dewangan, J; Divakar, A; Kumar, S; Mishra, S; Rath, SK; Sharma, D; Srivastava, S; Wahajuddin, M | 1 |
| Arteaga-Henríquez, G; Gisbert, L; Ramos-Quiroga, JA | 1 |
3 review(s) available for acetylcysteine and celecoxib
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Experimental evidence of pharmacological management of anchorage in Orthodontics: A systematic review.
Topics: Acetylcysteine; Animals; Anti-Inflammatory Agents; Antioxidants; Bone Remodeling; Celecoxib; Clodronic Acid; Diclofenac; Diphosphonates; Humans; Imidazoles; Interferon-gamma; Isoxazoles; Lactones; Mice; Orthodontic Anchorage Procedures; Osteoclasts; Osteoprotegerin; Pamidronate; Rats; Resveratrol; Stilbenes; Sulfones; Tooth Mobility; Tooth Movement Techniques; Zoledronic Acid | 2015 |
Immunoregulatory and/or Anti-inflammatory Agents for the Management of Core and Associated Symptoms in Individuals with Autism Spectrum Disorder: A Narrative Review of Randomized, Placebo-Controlled Trials.
Topics: Acetylcysteine; Anti-Inflammatory Agents; Autism Spectrum Disorder; Celecoxib; Fatty Acids, Omega-3; Humans; Immunologic Factors; Minocycline; Prednisolone; Randomized Controlled Trials as Topic | 2023 |
1 trial(s) available for acetylcysteine and celecoxib
| Article | Year |
|---|---|
Addition of an induction regimen of antiangiogenesis and antitumor immunity to standard chemotherapy improves survival in advanced malignancies.
Topics: Acetylcysteine; Angiogenesis Inhibitors; Antigens, Neoplasm; Antineoplastic Agents; Carcinoma; Carcinoma, Non-Small-Cell Lung; Celecoxib; Cyclophosphamide; Female; Humans; Immunization; Immunotherapy; Induction Chemotherapy; Kaplan-Meier Estimate; Male; Pancreatic Neoplasms; Prostatic Neoplasms; Pyrazoles; Sulfonamides | 2012 |
8 other study(ies) available for acetylcysteine and celecoxib
| Article | Year |
|---|---|
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
N-acetylcysteine and celecoxib lessen cadmium cytotoxicity which is associated with cyclooxygenase-2 up-regulation in mouse neuronal cells.
Topics: Acetylcysteine; Animals; Antioxidants; Base Sequence; Cadmium; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Cysteine Endopeptidases; Dinoprostone; DNA Primers; Isoenzymes; Mice; Multienzyme Complexes; Neurons; Prostaglandin-Endoperoxide Synthases; Proteasome Endopeptidase Complex; Pyrazoles; Sulfonamides; Tumor Cells, Cultured; Ubiquitin; Up-Regulation | 2002 |
Celecoxib activates PI-3K/Akt and mitochondrial redox signaling to enhance heme oxygenase-1-mediated anti-inflammatory activity in vascular endothelium.
Topics: Acetylcysteine; Celecoxib; Chromones; Endothelial Cells; Enzyme Induction; Heme Oxygenase-1; Humans; Lactones; Morpholines; NF-E2-Related Factor 2; Oxidation-Reduction; Phosphatidylinositol 3-Kinases; Protein Transport; Proto-Oncogene Proteins c-akt; Protoporphyrins; Pyrazoles; Signal Transduction; Sulfonamides; Sulfones; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 2010 |
The novel NF-κB inhibitor DHMEQ synergizes with celecoxib to exert antitumor effects on human liver cancer cells by a ROS-dependent mechanism.
Topics: Acetylcysteine; Antineoplastic Agents; Apoptosis; Benzamides; Carcinoma, Hepatocellular; Celecoxib; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cyclohexanones; Cyclooxygenase 2 Inhibitors; Drug Synergism; Endoplasmic Reticulum Stress; fas Receptor; Humans; Liver Neoplasms; NF-kappa B; Poly(ADP-ribose) Polymerases; Protein Serine-Threonine Kinases; Pyrazoles; Reactive Oxygen Species; Repressor Proteins; Sulfonamides | 2012 |
Nickel-regulated heart rate variability: the roles of oxidative stress and inflammation.
Topics: Acetylcysteine; Animals; Anti-Inflammatory Agents; Antioxidants; Celecoxib; Heart Rate; Inflammation; Injections, Intraperitoneal; Male; Models, Theoretical; Nickel; Oxidative Stress; Pyrazoles; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Sulfonamides | 2013 |
N-acetyl-cysteine in combination with celecoxib inhibits Deoxynivalenol induced skin tumor initiation via induction of autophagic pathways in swiss mice.
Topics: Acetylcysteine; Animals; Autophagy; Celecoxib; Mice; Skin Neoplasms; Trichothecenes | 2020 |